instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Transplant rejection'. | Acute heart transplantation from mechanical circulatory support in a human immunodeficiency virus-positive patient with fulminant myocarditis.
Since the establishment of highly active antiretroviral therapy, survival rates have improved among patients with human immunodeficiency virus infection giving them the possibil... | COBICISTAT\DARUNAVIR ETHANOLATE, ETRAVIRINE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 33634606 | 19,973,241 | 2021-04 |
What was the outcome of reaction 'Immunosuppressant drug level increased'? | Acute heart transplantation from mechanical circulatory support in a human immunodeficiency virus-positive patient with fulminant myocarditis.
Since the establishment of highly active antiretroviral therapy, survival rates have improved among patients with human immunodeficiency virus infection giving them the possibil... | Recovered | ReactionOutcome | CC BY-NC-ND | 33634606 | 19,973,241 | 2021-04 |
What was the outcome of reaction 'Transplant rejection'? | Acute heart transplantation from mechanical circulatory support in a human immunodeficiency virus-positive patient with fulminant myocarditis.
Since the establishment of highly active antiretroviral therapy, survival rates have improved among patients with human immunodeficiency virus infection giving them the possibil... | Recovered | ReactionOutcome | CC BY-NC-ND | 33634606 | 19,973,241 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple-drug resistance'. | Paraneoplastic Encephalitis Associated with Locally Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
Paraneoplastic neurologic diseases (PND) are rare but can occur in patients with common malignancies including breast cancer. In patients with hormone receptor (HR)-negative human epidermal grow... | ADO-TRASTUZUMAB EMTANSINE, DIVALPROEX SODIUM, FOSPHENYTOIN, LACOSAMIDE, LEVETIRACETAM, PERTUZUMAB, PHENYTOIN, TRASTUZUMAB, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY-NC | 33634625 | 19,418,864 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Seizure'. | Paraneoplastic Encephalitis Associated with Locally Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
Paraneoplastic neurologic diseases (PND) are rare but can occur in patients with common malignancies including breast cancer. In patients with hormone receptor (HR)-negative human epidermal grow... | ADO-TRASTUZUMAB EMTANSINE, DIVALPROEX SODIUM, FOSPHENYTOIN, LACOSAMIDE, LEVETIRACETAM, PERTUZUMAB, PHENYTOIN, TRASTUZUMAB, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY-NC | 33634625 | 19,418,864 | 2021-02 |
What was the outcome of reaction 'Seizure'? | Paraneoplastic Encephalitis Associated with Locally Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
Paraneoplastic neurologic diseases (PND) are rare but can occur in patients with common malignancies including breast cancer. In patients with hormone receptor (HR)-negative human epidermal grow... | Recovered | ReactionOutcome | CC BY-NC | 33634625 | 19,418,864 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperferritinaemia'. | Cytomegalovirus-Associated Hemophagocytic Syndrome Diagnosed by Liver Biopsy in a Kidney Transplant Recipient.
Hemophagocytic syndrome (HPS) is a rare but potentially life-threatening disease in kidney transplant recipients, and is caused by systemic proliferation of macrophages actively phagocytizing other blood cells... | MYCOPHENOLIC ACID, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33635018 | 18,985,815 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelosuppression'. | Cytomegalovirus-Associated Hemophagocytic Syndrome Diagnosed by Liver Biopsy in a Kidney Transplant Recipient.
Hemophagocytic syndrome (HPS) is a rare but potentially life-threatening disease in kidney transplant recipients, and is caused by systemic proliferation of macrophages actively phagocytizing other blood cells... | MYCOPHENOLIC ACID, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33635018 | 18,985,815 | 2021-03 |
What was the dosage of drug 'BASILIXIMAB'? | Cytomegalovirus-Associated Hemophagocytic Syndrome Diagnosed by Liver Biopsy in a Kidney Transplant Recipient.
Hemophagocytic syndrome (HPS) is a rare but potentially life-threatening disease in kidney transplant recipients, and is caused by systemic proliferation of macrophages actively phagocytizing other blood cells... | UNKNOWN | DrugDosageText | CC BY-NC | 33635018 | 19,289,501 | 2021-03 |
What was the dosage of drug 'UNSPECIFIED INGREDIENT'? | Cytomegalovirus-Associated Hemophagocytic Syndrome Diagnosed by Liver Biopsy in a Kidney Transplant Recipient.
Hemophagocytic syndrome (HPS) is a rare but potentially life-threatening disease in kidney transplant recipients, and is caused by systemic proliferation of macrophages actively phagocytizing other blood cells... | UNKNOWN | DrugDosageText | CC BY-NC | 33635018 | 19,289,501 | 2021-03 |
What was the outcome of reaction 'Cytomegalovirus hepatitis'? | Cytomegalovirus-Associated Hemophagocytic Syndrome Diagnosed by Liver Biopsy in a Kidney Transplant Recipient.
Hemophagocytic syndrome (HPS) is a rare but potentially life-threatening disease in kidney transplant recipients, and is caused by systemic proliferation of macrophages actively phagocytizing other blood cells... | Recovered | ReactionOutcome | CC BY-NC | 33635018 | 18,980,164 | 2021-03 |
What was the outcome of reaction 'Cytomegalovirus infection'? | Cytomegalovirus-Associated Hemophagocytic Syndrome Diagnosed by Liver Biopsy in a Kidney Transplant Recipient.
Hemophagocytic syndrome (HPS) is a rare but potentially life-threatening disease in kidney transplant recipients, and is caused by systemic proliferation of macrophages actively phagocytizing other blood cells... | Recovered | ReactionOutcome | CC BY-NC | 33635018 | 18,980,164 | 2021-03 |
What was the outcome of reaction 'Haemophagocytic lymphohistiocytosis'? | Cytomegalovirus-Associated Hemophagocytic Syndrome Diagnosed by Liver Biopsy in a Kidney Transplant Recipient.
Hemophagocytic syndrome (HPS) is a rare but potentially life-threatening disease in kidney transplant recipients, and is caused by systemic proliferation of macrophages actively phagocytizing other blood cells... | Recovered | ReactionOutcome | CC BY-NC | 33635018 | 18,980,164 | 2021-03 |
What was the outcome of reaction 'Hyperferritinaemia'? | Cytomegalovirus-Associated Hemophagocytic Syndrome Diagnosed by Liver Biopsy in a Kidney Transplant Recipient.
Hemophagocytic syndrome (HPS) is a rare but potentially life-threatening disease in kidney transplant recipients, and is caused by systemic proliferation of macrophages actively phagocytizing other blood cells... | Recovered | ReactionOutcome | CC BY-NC | 33635018 | 18,985,815 | 2021-03 |
What was the outcome of reaction 'Myelosuppression'? | Cytomegalovirus-Associated Hemophagocytic Syndrome Diagnosed by Liver Biopsy in a Kidney Transplant Recipient.
Hemophagocytic syndrome (HPS) is a rare but potentially life-threatening disease in kidney transplant recipients, and is caused by systemic proliferation of macrophages actively phagocytizing other blood cells... | Recovering | ReactionOutcome | CC BY-NC | 33635018 | 18,985,815 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute graft versus host disease'. | Metagenomic next-generation sequencing (mNGS) for diagnostically challenging infectious diseases in patients with acute leukemia.
This report shows the contribution of next-generation metagenomic sequencing (mNGS) as an alternative to challenging diagnostic infection in immunosuppressed individuals. Herein, we report t... | DAPTOMYCIN, MEROPENEM | DrugsGivenReaction | CC BY-NC-ND | 33639095 | 19,806,447 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute respiratory failure'. | Metagenomic next-generation sequencing (mNGS) for diagnostically challenging infectious diseases in patients with acute leukemia.
This report shows the contribution of next-generation metagenomic sequencing (mNGS) as an alternative to challenging diagnostic infection in immunosuppressed individuals. Herein, we report t... | DAPTOMYCIN, MEROPENEM | DrugsGivenReaction | CC BY-NC-ND | 33639095 | 19,806,447 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Metagenomic next-generation sequencing (mNGS) for diagnostically challenging infectious diseases in patients with acute leukemia.
This report shows the contribution of next-generation metagenomic sequencing (mNGS) as an alternative to challenging diagnostic infection in immunosuppressed individuals. Herein, we report t... | DAPTOMYCIN, MEROPENEM | DrugsGivenReaction | CC BY-NC-ND | 33639095 | 19,806,447 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Metagenomic next-generation sequencing (mNGS) for diagnostically challenging infectious diseases in patients with acute leukemia.
This report shows the contribution of next-generation metagenomic sequencing (mNGS) as an alternative to challenging diagnostic infection in immunosuppressed individuals. Herein, we report t... | DAPTOMYCIN, MEROPENEM | DrugsGivenReaction | CC BY-NC-ND | 33639095 | 19,806,447 | 2021 |
What was the outcome of reaction 'Acute graft versus host disease'? | Metagenomic next-generation sequencing (mNGS) for diagnostically challenging infectious diseases in patients with acute leukemia.
This report shows the contribution of next-generation metagenomic sequencing (mNGS) as an alternative to challenging diagnostic infection in immunosuppressed individuals. Herein, we report t... | Fatal | ReactionOutcome | CC BY-NC-ND | 33639095 | 19,806,447 | 2021 |
What was the outcome of reaction 'Acute respiratory failure'? | Metagenomic next-generation sequencing (mNGS) for diagnostically challenging infectious diseases in patients with acute leukemia.
This report shows the contribution of next-generation metagenomic sequencing (mNGS) as an alternative to challenging diagnostic infection in immunosuppressed individuals. Herein, we report t... | Fatal | ReactionOutcome | CC BY-NC-ND | 33639095 | 19,806,447 | 2021 |
What was the outcome of reaction 'Condition aggravated'? | Metagenomic next-generation sequencing (mNGS) for diagnostically challenging infectious diseases in patients with acute leukemia.
This report shows the contribution of next-generation metagenomic sequencing (mNGS) as an alternative to challenging diagnostic infection in immunosuppressed individuals. Herein, we report t... | Fatal | ReactionOutcome | CC BY-NC-ND | 33639095 | 19,806,447 | 2021 |
What was the outcome of reaction 'Drug ineffective'? | Metagenomic next-generation sequencing (mNGS) for diagnostically challenging infectious diseases in patients with acute leukemia.
This report shows the contribution of next-generation metagenomic sequencing (mNGS) as an alternative to challenging diagnostic infection in immunosuppressed individuals. Herein, we report t... | Fatal | ReactionOutcome | CC BY-NC-ND | 33639095 | 19,806,447 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | FLUOXETINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, LIOTHYRONINE SODIUM, METFORMIN HYDROCHLORIDE, OXAZOLAM, PSEUDOEPHEDRINE HYDROCHLORIDE, TOPIRAMATE | DrugsGivenReaction | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyspnoea exertional'. | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | FLUOXETINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, LIOTHYRONINE SODIUM, METFORMIN HYDROCHLORIDE, OXAZOLAM, PSEUDOEPHEDRINE HYDROCHLORIDE, TOPIRAMATE | DrugsGivenReaction | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Enzyme abnormality'. | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | FLUOXETINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, LIOTHYRONINE SODIUM, METFORMIN HYDROCHLORIDE, OXAZOLAM, PSEUDOEPHEDRINE HYDROCHLORIDE, TOPIRAMATE | DrugsGivenReaction | CC BY | 33639866 | 19,871,519 | 2021-02-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gait disturbance'. | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | FLUOXETINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, LIOTHYRONINE SODIUM, METFORMIN HYDROCHLORIDE, OXAZOLAM, PSEUDOEPHEDRINE HYDROCHLORIDE, TOPIRAMATE | DrugsGivenReaction | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypophagia'. | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | FLUOXETINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, LIOTHYRONINE SODIUM, METFORMIN HYDROCHLORIDE, OXAZOLAM, PSEUDOEPHEDRINE HYDROCHLORIDE, TOPIRAMATE | DrugsGivenReaction | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Memory impairment'. | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | FLUOXETINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, LIOTHYRONINE SODIUM, METFORMIN HYDROCHLORIDE, OXAZOLAM, PSEUDOEPHEDRINE HYDROCHLORIDE, TOPIRAMATE | DrugsGivenReaction | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Muscle atrophy'. | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | FLUOXETINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, LIOTHYRONINE SODIUM, METFORMIN HYDROCHLORIDE, OXAZOLAM, PSEUDOEPHEDRINE HYDROCHLORIDE, TOPIRAMATE | DrugsGivenReaction | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Muscular weakness'. | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | FLUOXETINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, LIOTHYRONINE SODIUM, METFORMIN HYDROCHLORIDE, OXAZOLAM, PSEUDOEPHEDRINE HYDROCHLORIDE, TOPIRAMATE | DrugsGivenReaction | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | FLUOXETINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, LIOTHYRONINE SODIUM, METFORMIN HYDROCHLORIDE, OXAZOLAM, PSEUDOEPHEDRINE HYDROCHLORIDE, TOPIRAMATE | DrugsGivenReaction | CC BY | 33639866 | 19,058,835 | 2021-02-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | FLUOXETINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, LIOTHYRONINE SODIUM, METFORMIN HYDROCHLORIDE, OXAZOLAM, PSEUDOEPHEDRINE HYDROCHLORIDE, TOPIRAMATE | DrugsGivenReaction | CC BY | 33639866 | 19,058,835 | 2021-02-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tachycardia'. | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | FLUOXETINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, LIOTHYRONINE SODIUM, METFORMIN HYDROCHLORIDE, OXAZOLAM, PSEUDOEPHEDRINE HYDROCHLORIDE, TOPIRAMATE | DrugsGivenReaction | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Weight decreased'. | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | FLUOXETINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, LIOTHYRONINE SODIUM, METFORMIN HYDROCHLORIDE, OXAZOLAM, PSEUDOEPHEDRINE HYDROCHLORIDE, TOPIRAMATE | DrugsGivenReaction | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
What was the administration route of drug 'METFORMIN HYDROCHLORIDE'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | Oral | DrugAdministrationRoute | CC BY | 33639866 | 19,025,448 | 2021-02-27 |
What was the administration route of drug 'TOPIRAMATE'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | Oral | DrugAdministrationRoute | CC BY | 33639866 | 19,025,448 | 2021-02-27 |
What was the dosage of drug 'FLUOXETINE HYDROCHLORIDE'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | UNKNOWN | DrugDosageText | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
What was the dosage of drug 'HYDROCHLOROTHIAZIDE'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | UNKNOWN | DrugDosageText | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
What was the dosage of drug 'LIOTHYRONINE SODIUM'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | UNKNOWN | DrugDosageText | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
What was the dosage of drug 'METFORMIN HYDROCHLORIDE'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | UNKNOWN | DrugDosageText | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
What was the dosage of drug 'OXAZOLAM'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | UNKNOWN | DrugDosageText | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
What was the dosage of drug 'PSEUDOEPHEDRINE HYDROCHLORIDE'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | UNKNOWN | DrugDosageText | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
What was the dosage of drug 'TOPIRAMATE'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | UNKNOWN | DrugDosageText | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
What was the outcome of reaction 'Decreased appetite'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | Recovered | ReactionOutcome | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
What was the outcome of reaction 'Dyspnoea exertional'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | Recovered | ReactionOutcome | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
What was the outcome of reaction 'Enzyme abnormality'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | Recovered | ReactionOutcome | CC BY | 33639866 | 19,871,519 | 2021-02-27 |
What was the outcome of reaction 'Gait disturbance'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | Recovered | ReactionOutcome | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
What was the outcome of reaction 'Hypophagia'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | Recovered | ReactionOutcome | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
What was the outcome of reaction 'Memory impairment'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | Recovered | ReactionOutcome | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
What was the outcome of reaction 'Muscle atrophy'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | Recovered | ReactionOutcome | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
What was the outcome of reaction 'Muscular weakness'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | Recovered | ReactionOutcome | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
What was the outcome of reaction 'Myopathy'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | Recovered | ReactionOutcome | CC BY | 33639866 | 19,025,448 | 2021-02-27 |
What was the outcome of reaction 'Tachycardia'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | Recovered | ReactionOutcome | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
What was the outcome of reaction 'Weight decreased'? | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
BACKGROUND
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a treatable lipid metabolism disorder that presents as myopathy and episodic metabolic crisis. The metabolic crisis is typically associate... | Recovered | ReactionOutcome | CC BY | 33639866 | 19,084,520 | 2021-02-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebral infarction'. | An unusual case of Cardiobacterium valvarum causing aortic endograft infection and osteomyelitis.
BACKGROUND
HACEK (Haemophilus spp., Aggregatibacter spp., Cardiobacterium spp., Eikenella corrodens, and Kingella spp.) group organisms are responsible for 0.8% to 6% of all infective endocarditis cases, with Cardiobacteri... | AMLODIPINE BESYLATE, ASPIRIN, ATORVASTATIN, CARVEDILOL, EZETIMIBE, LISINOPRIL | DrugsGivenReaction | CC BY | 33639961 | 19,175,607 | 2021-02-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhagic transformation stroke'. | An unusual case of Cardiobacterium valvarum causing aortic endograft infection and osteomyelitis.
BACKGROUND
HACEK (Haemophilus spp., Aggregatibacter spp., Cardiobacterium spp., Eikenella corrodens, and Kingella spp.) group organisms are responsible for 0.8% to 6% of all infective endocarditis cases, with Cardiobacteri... | AMLODIPINE BESYLATE, ASPIRIN, ATORVASTATIN, CARVEDILOL, EZETIMIBE, LISINOPRIL | DrugsGivenReaction | CC BY | 33639961 | 19,175,607 | 2021-02-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vascular graft infection'. | An unusual case of Cardiobacterium valvarum causing aortic endograft infection and osteomyelitis.
BACKGROUND
HACEK (Haemophilus spp., Aggregatibacter spp., Cardiobacterium spp., Eikenella corrodens, and Kingella spp.) group organisms are responsible for 0.8% to 6% of all infective endocarditis cases, with Cardiobacteri... | AMLODIPINE BESYLATE, ASPIRIN, ATORVASTATIN, CARVEDILOL, EZETIMIBE, LISINOPRIL | DrugsGivenReaction | CC BY | 33639961 | 19,175,607 | 2021-02-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute respiratory failure'. | CCR4-positive peripheral T-cell lymphoma presenting as eosinophilic pneumonia and developing from prolonged pustular psoriasis.
A 29-year-old woman with chronic, prolonged pustular psoriasis was admitted to our hospital because of high-grade fever and a systemic skin rash. General examination revealed a whole-body skin... | CYCLOSPORINE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33641488 | 19,179,180 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Eosinophilic pneumonia'. | CCR4-positive peripheral T-cell lymphoma presenting as eosinophilic pneumonia and developing from prolonged pustular psoriasis.
A 29-year-old woman with chronic, prolonged pustular psoriasis was admitted to our hospital because of high-grade fever and a systemic skin rash. General examination revealed a whole-body skin... | CYCLOSPORINE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33641488 | 19,179,180 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Live birth'. | CCR4-positive peripheral T-cell lymphoma presenting as eosinophilic pneumonia and developing from prolonged pustular psoriasis.
A 29-year-old woman with chronic, prolonged pustular psoriasis was admitted to our hospital because of high-grade fever and a systemic skin rash. General examination revealed a whole-body skin... | CYCLOSPORINE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33641488 | 19,179,180 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | CCR4-positive peripheral T-cell lymphoma presenting as eosinophilic pneumonia and developing from prolonged pustular psoriasis.
A 29-year-old woman with chronic, prolonged pustular psoriasis was admitted to our hospital because of high-grade fever and a systemic skin rash. General examination revealed a whole-body skin... | CYCLOSPORINE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33641488 | 19,179,180 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Meningitis viral'. | CCR4-positive peripheral T-cell lymphoma presenting as eosinophilic pneumonia and developing from prolonged pustular psoriasis.
A 29-year-old woman with chronic, prolonged pustular psoriasis was admitted to our hospital because of high-grade fever and a systemic skin rash. General examination revealed a whole-body skin... | CYCLOSPORINE, METHOTREXATE, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33641488 | 19,169,598 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | CCR4-positive peripheral T-cell lymphoma presenting as eosinophilic pneumonia and developing from prolonged pustular psoriasis.
A 29-year-old woman with chronic, prolonged pustular psoriasis was admitted to our hospital because of high-grade fever and a systemic skin rash. General examination revealed a whole-body skin... | CYCLOSPORINE, METHOTREXATE, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33641488 | 19,169,598 | 2021-02 |
What was the administration route of drug 'PREDNISOLONE'? | CCR4-positive peripheral T-cell lymphoma presenting as eosinophilic pneumonia and developing from prolonged pustular psoriasis.
A 29-year-old woman with chronic, prolonged pustular psoriasis was admitted to our hospital because of high-grade fever and a systemic skin rash. General examination revealed a whole-body skin... | Oral | DrugAdministrationRoute | CC BY-NC | 33641488 | 19,169,598 | 2021-02 |
What was the outcome of reaction 'Acute respiratory failure'? | CCR4-positive peripheral T-cell lymphoma presenting as eosinophilic pneumonia and developing from prolonged pustular psoriasis.
A 29-year-old woman with chronic, prolonged pustular psoriasis was admitted to our hospital because of high-grade fever and a systemic skin rash. General examination revealed a whole-body skin... | Recovered | ReactionOutcome | CC BY-NC | 33641488 | 19,179,180 | 2021-02 |
What was the outcome of reaction 'Eosinophilic pneumonia'? | CCR4-positive peripheral T-cell lymphoma presenting as eosinophilic pneumonia and developing from prolonged pustular psoriasis.
A 29-year-old woman with chronic, prolonged pustular psoriasis was admitted to our hospital because of high-grade fever and a systemic skin rash. General examination revealed a whole-body skin... | Recovered | ReactionOutcome | CC BY-NC | 33641488 | 19,179,180 | 2021-02 |
What was the outcome of reaction 'Meningitis viral'? | CCR4-positive peripheral T-cell lymphoma presenting as eosinophilic pneumonia and developing from prolonged pustular psoriasis.
A 29-year-old woman with chronic, prolonged pustular psoriasis was admitted to our hospital because of high-grade fever and a systemic skin rash. General examination revealed a whole-body skin... | Recovered | ReactionOutcome | CC BY-NC | 33641488 | 19,169,598 | 2021-02 |
What was the outcome of reaction 'Peripheral T-cell lymphoma unspecified'? | CCR4-positive peripheral T-cell lymphoma presenting as eosinophilic pneumonia and developing from prolonged pustular psoriasis.
A 29-year-old woman with chronic, prolonged pustular psoriasis was admitted to our hospital because of high-grade fever and a systemic skin rash. General examination revealed a whole-body skin... | Recovered | ReactionOutcome | CC BY-NC | 33641488 | 19,169,598 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Loss of consciousness'. | Polymorphic Ventricular Tachycardia with QT Interval Prolongation Due to a Brain Tumor.
We herein report the case of a 20-year-old man with a history of epilepsy who presented with frequent transient loss of consciousness (T-LOC) and polymorphic ventricular tachycardia (VT) with QT interval prolongation. Blood investig... | LEVETIRACETAM, VALPROATE SODIUM | DrugsGivenReaction | CC BY-NC-ND | 33642483 | 19,997,413 | 2021-08-15 |
What was the administration route of drug 'LEVETIRACETAM'? | Polymorphic Ventricular Tachycardia with QT Interval Prolongation Due to a Brain Tumor.
We herein report the case of a 20-year-old man with a history of epilepsy who presented with frequent transient loss of consciousness (T-LOC) and polymorphic ventricular tachycardia (VT) with QT interval prolongation. Blood investig... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33642483 | 19,997,413 | 2021-08-15 |
What was the administration route of drug 'VALPROATE SODIUM'? | Polymorphic Ventricular Tachycardia with QT Interval Prolongation Due to a Brain Tumor.
We herein report the case of a 20-year-old man with a history of epilepsy who presented with frequent transient loss of consciousness (T-LOC) and polymorphic ventricular tachycardia (VT) with QT interval prolongation. Blood investig... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33642483 | 19,997,413 | 2021-08-15 |
What was the outcome of reaction 'Loss of consciousness'? | Polymorphic Ventricular Tachycardia with QT Interval Prolongation Due to a Brain Tumor.
We herein report the case of a 20-year-old man with a history of epilepsy who presented with frequent transient loss of consciousness (T-LOC) and polymorphic ventricular tachycardia (VT) with QT interval prolongation. Blood investig... | Recovered | ReactionOutcome | CC BY-NC-ND | 33642483 | 19,997,413 | 2021-08-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas.
A 74-year-old woman with a cyst in her pancreatic tail was referred to our hospital. Computed tomography confirmed a large cystic lesion with irregular wall thickening, abdominal lymph node swelling, and ascites. We dia... | FLUOROURACIL, GEMCITABINE, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, LEUCOVORIN CALCIUM, OXALIPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 33642489 | 20,980,647 | 2021-08-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuropathy peripheral'. | Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas.
A 74-year-old woman with a cyst in her pancreatic tail was referred to our hospital. Computed tomography confirmed a large cystic lesion with irregular wall thickening, abdominal lymph node swelling, and ascites. We dia... | FLUOROURACIL, GEMCITABINE, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, LEUCOVORIN CALCIUM, OXALIPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 33642489 | 20,980,647 | 2021-08-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas.
A 74-year-old woman with a cyst in her pancreatic tail was referred to our hospital. Computed tomography confirmed a large cystic lesion with irregular wall thickening, abdominal lymph node swelling, and ascites. We dia... | FLUOROURACIL, GEMCITABINE, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, LEUCOVORIN CALCIUM, OXALIPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 33642489 | 20,980,647 | 2021-08-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas.
A 74-year-old woman with a cyst in her pancreatic tail was referred to our hospital. Computed tomography confirmed a large cystic lesion with irregular wall thickening, abdominal lymph node swelling, and ascites. We dia... | FLUOROURACIL, GEMCITABINE, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, LEUCOVORIN CALCIUM, OXALIPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 33642489 | 20,980,647 | 2021-08-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas.
A 74-year-old woman with a cyst in her pancreatic tail was referred to our hospital. Computed tomography confirmed a large cystic lesion with irregular wall thickening, abdominal lymph node swelling, and ascites. We dia... | FLUOROURACIL, IRINOTECAN, LEVOLEUCOVORIN CALCIUM, OXALIPLATIN | DrugsGivenReaction | CC BY-NC-ND | 33642489 | 20,034,993 | 2021-08-15 |
What was the administration route of drug 'FLUOROURACIL'? | Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas.
A 74-year-old woman with a cyst in her pancreatic tail was referred to our hospital. Computed tomography confirmed a large cystic lesion with irregular wall thickening, abdominal lymph node swelling, and ascites. We dia... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 33642489 | 20,034,993 | 2021-08-15 |
What was the administration route of drug 'GIMERACIL\OTERACIL\TEGAFUR'? | Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas.
A 74-year-old woman with a cyst in her pancreatic tail was referred to our hospital. Computed tomography confirmed a large cystic lesion with irregular wall thickening, abdominal lymph node swelling, and ascites. We dia... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33642489 | 20,980,647 | 2021-08-15 |
What was the administration route of drug 'IRINOTECAN'? | Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas.
A 74-year-old woman with a cyst in her pancreatic tail was referred to our hospital. Computed tomography confirmed a large cystic lesion with irregular wall thickening, abdominal lymph node swelling, and ascites. We dia... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 33642489 | 20,034,993 | 2021-08-15 |
What was the administration route of drug 'LEVOLEUCOVORIN CALCIUM'? | Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas.
A 74-year-old woman with a cyst in her pancreatic tail was referred to our hospital. Computed tomography confirmed a large cystic lesion with irregular wall thickening, abdominal lymph node swelling, and ascites. We dia... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 33642489 | 20,034,993 | 2021-08-15 |
What was the administration route of drug 'OXALIPLATIN'? | Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas.
A 74-year-old woman with a cyst in her pancreatic tail was referred to our hospital. Computed tomography confirmed a large cystic lesion with irregular wall thickening, abdominal lymph node swelling, and ascites. We dia... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 33642489 | 20,034,993 | 2021-08-15 |
What was the dosage of drug 'GEMCITABINE'? | Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas.
A 74-year-old woman with a cyst in her pancreatic tail was referred to our hospital. Computed tomography confirmed a large cystic lesion with irregular wall thickening, abdominal lymph node swelling, and ascites. We dia... | 1000 MILLIGRAM/SQ. METER, ON DAY 1, 8, 15, EVERY 4 WEEKS | DrugDosageText | CC BY-NC-ND | 33642489 | 20,980,647 | 2021-08-15 |
What was the dosage of drug 'GIMERACIL\OTERACIL\TEGAFUR'? | Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas.
A 74-year-old woman with a cyst in her pancreatic tail was referred to our hospital. Computed tomography confirmed a large cystic lesion with irregular wall thickening, abdominal lymph node swelling, and ascites. We dia... | 100 MILLIGRAM, DAILY | DrugDosageText | CC BY-NC-ND | 33642489 | 20,980,647 | 2021-08-15 |
What was the dosage of drug 'LEUCOVORIN CALCIUM'? | Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas.
A 74-year-old woman with a cyst in her pancreatic tail was referred to our hospital. Computed tomography confirmed a large cystic lesion with irregular wall thickening, abdominal lymph node swelling, and ascites. We dia... | 300 MILLIGRAM/SQ. METER | DrugDosageText | CC BY-NC-ND | 33642489 | 20,980,647 | 2021-08-15 |
What was the dosage of drug 'LEUCOVORIN'? | Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas.
A 74-year-old woman with a cyst in her pancreatic tail was referred to our hospital. Computed tomography confirmed a large cystic lesion with irregular wall thickening, abdominal lymph node swelling, and ascites. We dia... | 300 MG/M2, CYCLIC(EVERY 2 WEEKS) | DrugDosageText | CC BY-NC-ND | 33642489 | 20,572,580 | 2021-08-15 |
What was the dosage of drug 'LEVOLEUCOVORIN CALCIUM'? | Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas.
A 74-year-old woman with a cyst in her pancreatic tail was referred to our hospital. Computed tomography confirmed a large cystic lesion with irregular wall thickening, abdominal lymph node swelling, and ascites. We dia... | 300 MG/M2 ONCE IN 2WEEKS | DrugDosageText | CC BY-NC-ND | 33642489 | 20,034,993 | 2021-08-15 |
What was the dosage of drug 'PACLITAXEL'? | Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas.
A 74-year-old woman with a cyst in her pancreatic tail was referred to our hospital. Computed tomography confirmed a large cystic lesion with irregular wall thickening, abdominal lymph node swelling, and ascites. We dia... | 125 MILLIGRAM/SQ. METER, ON DAY 1, 8, 15, EVERY 4 WEEKS | DrugDosageText | CC BY-NC-ND | 33642489 | 20,980,647 | 2021-08-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Enterocolitis'. | Rituximab-induced Ileocolitis in a Patient with Gastric MALToma: A Case Report and Literature Review.
Rituximab (RTX) is effective for treating cancer, but reports of RTX-associated enterocolitis are limited. We herein report the case of a 65-year-old man who developed RTX-induced ileocolitis. He was diagnosed with gas... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 33642561 | 19,072,196 | 2021 |
What was the outcome of reaction 'Enterocolitis'? | Rituximab-induced Ileocolitis in a Patient with Gastric MALToma: A Case Report and Literature Review.
Rituximab (RTX) is effective for treating cancer, but reports of RTX-associated enterocolitis are limited. We herein report the case of a 65-year-old man who developed RTX-induced ileocolitis. He was diagnosed with gas... | Recovered | ReactionOutcome | CC BY-NC-ND | 33642561 | 19,072,196 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | Potentially Inappropriate Prescriptions to Older Patients in Emergency Departments in South Korea: A Retrospective Study.
The purpose of this study was to evaluate the incidence of the administration of potentially inappropriate medications (PIMs) and the potential drug-drug interactions (pDDIs) in older patients in em... | ACETAMINOPHEN\TRAMADOL HYDROCHLORIDE, AMITRIPTYLINE, CYCLOBENZAPRINE, DULOXETINE, HALOPERIDOL, IMIPRAMINE, NORTRIPTYLINE, QUETIAPINE, TRAMADOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33642859 | 19,277,465 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lyme disease'. | Case Report: Borrelia-DNA Revealed the Cause of Arthritis and Dermatitis During Treatment With Rituximab.
Borrelia-specific antibodies in serum did not contribute to the diagnosis of Borrelia arthritis or Borrelia-associated dermatitis in a young woman with ongoing treatment with rituximab due to multiple sclerosis. Th... | ACETAMINOPHEN, RITUXIMAB | DrugsGivenReaction | CC BY | 33643217 | 19,006,938 | 2021 |
What was the outcome of reaction 'Lyme disease'? | Case Report: Borrelia-DNA Revealed the Cause of Arthritis and Dermatitis During Treatment With Rituximab.
Borrelia-specific antibodies in serum did not contribute to the diagnosis of Borrelia arthritis or Borrelia-associated dermatitis in a young woman with ongoing treatment with rituximab due to multiple sclerosis. Th... | Recovering | ReactionOutcome | CC BY | 33643217 | 19,006,938 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Tamoxifen Therapy for Recurrent Mucosal Bleeding in Hereditary Hemorrhagic Telangiectasia.
A 60-year-old Caucasian man had a 55-year history of recurrent severe epistaxis and later presented with multiple gastrointestinal (GI) bleeding from hereditary hemorrhagic telangiectasia (HHT). Bleeding was exacerbated due to co... | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT, TRANEXAMIC ACID | DrugsGivenReaction | CC BY-NC | 33643506 | 19,003,653 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'No adverse event'. | Tamoxifen Therapy for Recurrent Mucosal Bleeding in Hereditary Hemorrhagic Telangiectasia.
A 60-year-old Caucasian man had a 55-year history of recurrent severe epistaxis and later presented with multiple gastrointestinal (GI) bleeding from hereditary hemorrhagic telangiectasia (HHT). Bleeding was exacerbated due to co... | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT, TRANEXAMIC ACID | DrugsGivenReaction | CC BY-NC | 33643506 | 19,003,653 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | CAPECITABINE, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | CAPECITABINE, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anal fistula'. | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | CAPECITABINE, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chest pain'. | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | CAPECITABINE, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.